Clinical Trial Update: Ketamine in the Treatment of Suicidal Depression [Phase 4]

View source ↗

Summary

Phase 4 trial update on ketamine for suicidal depression, documenting completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicidal Ideation

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Major Depressive Disorder, Suicidal Ideation | Phase 4 | Status: COMPLETED | Results posted: 2020-03-11